Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia.

Autor: Palić S; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Chu WY; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Sundar S; Department of Medicine, Banaras Hindu University, Varanasi, India., Mondal D; Centre for Nutrition and Food Security (CNFS), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh., Das P; Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna, India., Pandey K; Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna, India., Raja S; Drugs for Neglected Diseases initiative (DNDi) South Asia, New Delhi, India., Rijal S; Drugs for Neglected Diseases initiative (DNDi) South Asia, New Delhi, India., Roseboom IC; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Hamadeh A; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada., Malik PRV; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada., Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Sjögren E; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.; Pharmetheus AB, Uppsala, Sweden., Alves F; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Dorlo TPC; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pharmacy, Uppsala University, Uppsala, Sweden.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Jul 01; Vol. 79 (7), pp. 1547-1554.

Pediatric Dose Selection for Therapeutic Proteins.

Autor: Malik PRV; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada., Temrikar ZH; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, Tennessee, USA., Chelle P; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada., Edginton AN; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada., Meibohm B; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 2021 Jun; Vol. 61 Suppl 1, pp. S193-S206.

Integration of Ontogeny Into a Physiologically Based Pharmacokinetic Model for Monoclonal Antibodies in Premature Infants.

Autor: Malik PRV; School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada., Edginton AN; School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada.

Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 2020 Apr; Vol. 60 (4), pp. 466-476. Date of Electronic Publication: 2019 Nov 14.

Epigallocatechin-3-gallate at the nanoscale: a new strategy for cancer treatment.

Autor: Sun, Wenxue^1,2 (AUTHOR), Yang, Yizhuang³ (AUTHOR), Wang, Cuiyun⁴ (AUTHOR), Liu, Mengmeng⁴ (AUTHOR), Wang, Jianhua¹ (AUTHOR), Qiao, Sen⁵ (AUTHOR), Jiang, Pei² (AUTHOR) jiangpeicsu@sina.com, Sun, Changgang¹ (AUTHOR) scgdoctor@126.com, Jiang, Shulong^6,7 (AUTHOR) jnsljiang@163.com

Publikováno v: Pharmaceutical Biology. Dec2024, Vol. 62 Issue 1, p676-690. 15p.

Informing the risk assessment related to lactation and drug exposure: A physiologically based pharmacokinetic lactation model for pregabalin.

Autor: Humerickhouse, Cameron¹ (AUTHOR), Pressly, Michelle² (AUTHOR), Lin, Zhoumeng^1,3,4 (AUTHOR), Guinn, Daphne² (AUTHOR), Samuels, Sherbet² (AUTHOR), Pfuma Fletcher, Elimika² (AUTHOR) elimika.fletcher@fda.hhs.gov, Schmidt, Stephan¹ (AUTHOR) sschmidt@cop.ufl.edu

Publikováno v: CPT: Pharmacometrics & Systems Pharmacology. Nov2024, Vol. 13 Issue 11, p1953-1966. 14p.